Aug 7, 2019 6:30 am EDT Rexahn Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Update on RX-3117 Development
Jul 22, 2019 8:00 am EDT Ocuphire Pharma Raises Over $5 Million to Complete Multiple Late Phase 2 Clinical Trials